| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |